This study aimed to elucidate the molecular mechanisms through which the TET1/SMAD4/GATA6 regulatory axis governs CAF activation in breast cancer, focusing on its role in sustaining TGF-β signaling, promoting stromal-tumor crosstalk, and driving tumor progression. The gene discussed is TET1; the disease is breast carcinoma.